Epidemiological Alert, Nosocomial transmission of NDM-type multiresistant bacteria (19 December 2012)
Alerta epidemiológica, Transmisión de bacterias multirresistentes tipo NDM en servicios de atención de salud (19 diciembre 2012)
Date
2012Metadata
Show full item recordAbstract
Since 2008, there has been documented worldwide circulation of microorganisms with antimicrobial resistance mechanism, called "New Delhi Metallo-β-lactamase" (NDM), which confers resistance, to all β -lactam antibiotics except aztreonam. These microorganisms are considered multiresistant because they have other mechanisms of resistance to β –lactam antimicrobial drugs, leaving very few therapeutic options for treating patients infected with these bacteria. Desde 2008, se documentó a nivel mundial la circulación de microorganismos con mecanismo de resistencia antimicrobiana, denominado “New Delhi Metalobetalactamasa” (NDM), el cual confiere resistencia a todos los antibióticos betaláctamicos excepto aztreonam. Estos microrganismos son considerados multirresistentes debido a que presentan otros mecanismos de resistencia a antibióticos no betalactámicos, lo cual deja muy pocas opciones terapéuticas para tratar a pacientes infectados con estas bacterias.
Subject
Collections
Related items
Showing items related by title, author, creator and subject.
-
Saavedra, Julio C.; Fonseca, Deisy; Abrahamyan, Arpine; Thekkur, Pruthu; Timire, Collins; Reyes, Jorge; Zachariah, Rony; Agudelo, Lorena G. (2023)[ABSTRACT]. Objectives. To assess antibiotic susceptibility of World Health Organization (WHO) priority bacteria (Acine- tobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Salmonella spp., Staphylococcus aureus, ...
-
Allel, Kasim; García, Patricia; Labarca, Jaime; Munita, José M.; Rendic, Magdalena; Undurraga, Eduardo A.; Grupo Colaborativo de Resistencia Bacteriana (2020)[ABSTRACT]. Objective. To identify socioeconomic factors associated with antimicrobial resistance of Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli in Chilean hospitals (2008–2017). Methods. We reviewed ...
-
Bastidas-Caldes, Carlos; Guerrero-Freire, Salomé; Ortuño-Gutiérrez, Nimer; Sunyoto, Temmy; Gomes-Dias, Cícero Armídio; Ramírez, Maria Soledad; Calero-Cáceres, William; Harries, Anthony D.; Rey, Joaquín; de Waard, Jacobus H.; Calvopiña, Manuel (2023)[ABSTRACT]. Objective. Colistin is an antibiotic of last resort for treating serious Gram-negative bacterial infections. However, the misuse of colistin, especially as an animal growth promoter, has contributed to increasing ...